Medpace Holdings, Inc. (MEDP)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenue, net (includes 16.9 million and 11.2 million with related parties for the three months ended june30, 2025 and 2024, respectively, and 30.7 million and 24.0 million with related parties for the six months ended june30, 2025 and 2024, respectively) | 603,311 | - | 533,317 | 528,104 |
| Selling, general and administrative | 46,664 | - | 49,217 | 41,453 |
| Reimbursable Out Of Pocket Costs | 237,472 | - | - | - |
| Direct Costs | 185,826 | - | - | - |
| Total direct costs | 423,298 | - | 364,309 | 374,266 |
| Depreciation | 6,777 | - | 7,158 | 6,874 |
| Amortization | 237 | - | 360 | 361 |
| Total operating expenses | 476,976 | - | 421,044 | 422,954 |
| Income from operations | 126,335 | 113,523 | 112,273 | 105,150 |
| Miscellaneous (expense) income, net | -2,875 | -1,816 | -1,025 | -133 |
| Interest income, net | 1,078 | 6,463 | 7,528 | 5,465 |
| Total other (expense) income, net | -1,797 | 4,647 | 6,503 | 5,332 |
| Income before income taxes | 124,538 | 118,170 | 118,776 | 110,482 |
| Income tax provision | 34,278 | 3,575 | 22,350 | 22,131 |
| Net income | 90,260 | 114,595 | 96,426 | 88,351 |
| Basic (in dollars per share) | 3.16 | 3.77 | 3.11 | 2.85 |
| Basic (in shares) | 28,601,000 | 30,387,000 | 31,047,000 | 30,990,000 |
| Diluted (in dollars per share) | 3.1 | 3.67 | 3.01 | 2.75 |
| Diluted (in shares) | 29,143,000 | 31,196,000 | 32,088,000 | 32,086,000 |